Faculty Position: Physician, Onco-Pulmonary Service, Department of Medicine

Memorial Sloan Kettering Cancer Center•New York, NY

9d•Onsite

About The Position

The Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK) is seeking a highly motivated physician with training in Pulmonary Medicine for an academic clinician faculty position. This role is focused on onco-pulmonology and the clinical care of patients with cancer who develop pulmonary complications related to malignancy, cancer therapy, immune-based treatments, transplantation, infection, and underlying chronic lung disease. The Pulmonary Service provides specialized expertise in Onco-Pulmonary and General Pulmonary Medicine, with an emphasis on longitudinal, multidisciplinary oncologic care; management of immunocompromised hosts; evaluation and treatment of drug-induced and radiation-induced pneumonitis; pulmonary complications of cellular therapy and stem cell transplantation; peri-operative pulmonary risk assessment; and chronic lung diseases including COPD, asthma, interstitial lung disease, bronchiectasis, pulmonary nodules, and chronic cough. The successful candidate will have the opportunity to help grow MSK’s multidisciplinary immune-related adverse event (IRAE) program, with a particular focus on pulmonary toxicities from immune checkpoint inhibitors and other novel cancer therapies. The position includes robust clinical and research opportunities to build collaborative programs across the Department of Medicine, including partnerships with solid tumor oncology, hematologic malignancies, subspecialty medicine, radiology, pathology, infectious diseases, rheumatology, dermatology, cardiology, critical care, and supportive care. We are particularly interested in candidates who wish to expand clinical research and clinical trials focused on pulmonary toxicities, IRAEs, and multidisciplinary models of care for patients receiving advanced oncologic therapies. Pulmonary hosts two fellowships, one in Pulmonary & Critical Care Medicine and the other in Interventional Pulmonology and collaborate with an integrated Pulmonary APP inpatient team. The Pulmonary research portfolio continues to expand in breadth, with active publications, new prospective clinical trials and external funding. The largest of MSK’s clinical departments, the Department of Medicine (DoM) encompasses experts in solid tumor oncology, hematologic malignancies, subspecialty medicine and supportive and acute care services. Offering a range of services both in multiple sites in New York City and at their suburban outpatient locations in our Regional Care Network (RCN), DoM physicians oversee the care of the whole patient. The RCN serves the areas surrounding Manhattan and extends from Southern New Jersey to Eastern Long Island and brings the same high level of expertise, clinical care, and access to clinical trial protocols that are available at our main campus in New York City.

Requirements

Board Eligible/Board Certified in Pulmonary Medicine
Strong interest in the multidisciplinary management of patients with cancer, including immunocompromised patients and those with pulmonary complications of oncologic therapies.
Excellence in clinical care
Commitment to academic medicine
Ability to work in a cohesive, dynamic team environment

Nice To Haves

Experience or interest in clinical research
Experience or interest in clinical trials
Experience or interest in program development
Experience or interest in collaborative investigation in pulmonary toxicities and IRAEs

Responsibilities

Clinical care of patients with cancer who develop pulmonary complications related to malignancy, cancer therapy, immune-based treatments, transplantation, infection, and underlying chronic lung disease.
Provide specialized expertise in Onco-Pulmonary and General Pulmonary Medicine.
Longitudinal, multidisciplinary oncologic care.
Management of immunocompromised hosts.
Evaluation and treatment of drug-induced and radiation-induced pneumonitis.
Management of pulmonary complications of cellular therapy and stem cell transplantation.
Peri-operative pulmonary risk assessment.
Management of chronic lung diseases including COPD, asthma, interstitial lung disease, bronchiectasis, pulmonary nodules, and chronic cough.
Help grow MSK’s multidisciplinary immune-related adverse event (IRAE) program, with a particular focus on pulmonary toxicities from immune checkpoint inhibitors and other novel cancer therapies.
Build collaborative programs across the Department of Medicine, including partnerships with solid tumor oncology, hematologic malignancies, subspecialty medicine, radiology, pathology, infectious diseases, rheumatology, dermatology, cardiology, critical care, and supportive care.
Expand clinical research and clinical trials focused on pulmonary toxicities, IRAEs, and multidisciplinary models of care for patients receiving advanced oncologic therapies.